Covid Vaccine Corbevax
- All
- News
- Videos
-
India's Corbevax Vaccine Gets WHO Emergency Use Listing Authorisation
India's COVID-19 vaccine, Corbevax, has been granted an Emergency Use Listing by the World Health Organisation, the company which manufactures it in India said Hyderabad today.
-
100 Million Corbevax Doses Supplied To Centre, Says Biological E
Biological E. Ltd (BE) on Thursday said it has delivered 10 crore (100 million) doses of its COVID-19 vaccine, Corbevax, to the Centre so far.
-
Corbevax Approved As Booster Dose For Adults Vaccinated With Covaxin, Covishield
The government on Wednesday approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin.
-
Corbevax Cleared As Covid Booster Shot For Those 18 And Above
Biological E's COVID-19 vaccine Corbevax has been cleared for booster shot for those 18 and above.
-
Vaccine For 12-14 Age Group: Delhi Parents Feel Relieved, Say Apt Move Ahead Of School Reopening
The COVID-19 vaccine to be administered to the 12-14 years age group would be Corbevax manufactured by Biological E. Limited, Hyderabad.
-
Centre Releases Guidelines For Covid Vaccination Of 12-14 Age Group
The Centre today released guidelines for COVID-19 vaccination of children between 12-14 years that will begin from March 16 and said only Corbevax vaccine would be used for the beneficiaries of this age group.
-
Influential US Congress Members Urge Vaccine Collaboration With India
Members of America's influential Congressional Hispanic Caucus have urged US President Joe Biden to champion vaccine collaboration with India to bring an end to the COVID-19 pandemic.
-
Biological E's Corbevax Is Second Covid Vaccine For Children In India
A second COVID-19 vaccine for children has received emergency use authorisation in India. Biological E Ltd's Corbevax has got EUA for children and teens between 12 and 18 years, the vaccine-maker said in a statement today.
-
Pharma Stocks Gain After Centre Approves Use Of COVID Pill Molnupiravir
Pharma Stocks Today: Pharmaceutical shares such as Cipla, Dr Reddy's Laboratories, Torrent Pharma, Sun Pharma Industries gained around two per cent each on Wednesday
-
Biological E Aims To Produce 100 Million Doses Of Corbevax Every Month From Feb 2022
Biological E. Limited plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating over 100 million doses per month from February 2022.
-
Will 2 New Vaccines Be Used As Boosters? Decision "Within Days"
The government will soon take a call whether the two new Covid vaccines approved today -- Corbevax and Covovax -- may be used for booster doses. Sources told NDTV that a decision is expected "within days".
-
India's 2 New Covid Vaccines: What You Need To Know
The two latest vaccines cleared by India are Corbevax and Covovax. The anti-viral drug Molnupiravir can be used during emergency.
-
India Clears 2 New Vaccines And Merck's Covid Pill: 10 Points
The centre cleared two more vaccines today and one anti-viral drug to boost the fight against the COVID-19 pandemic. The two latest vaccines cleared by India are Corbevax and Covovax. The anti-viral drug Molnupiravir can be used during emergency.
-
Hyderabad's Biological E Expects To Rollout Corbevax Covid Vaccine By November-End
Biological E. Limited (BE) is expecting its COVID-19 vaccine Corbevax to be rolled out by the end of November even as the city-based firm is getting ready with 100 million doses for the launch, Mahima Datla, Managing Director, BE said on Monday.
-
Biological E Seeks Regulator's Nod For Phase-3 Trial Of Booster Dose
Biological E has sought permission from India's drug regulator to conduct the phase-3 clinical trial for its COVID-19 vaccine Corbevax as a single booster dose for those who have been fully vaccinated with Covishield or Covaxin.
-
India's Corbevax Vaccine Gets WHO Emergency Use Listing Authorisation
India's COVID-19 vaccine, Corbevax, has been granted an Emergency Use Listing by the World Health Organisation, the company which manufactures it in India said Hyderabad today.
-
100 Million Corbevax Doses Supplied To Centre, Says Biological E
Biological E. Ltd (BE) on Thursday said it has delivered 10 crore (100 million) doses of its COVID-19 vaccine, Corbevax, to the Centre so far.
-
Corbevax Approved As Booster Dose For Adults Vaccinated With Covaxin, Covishield
The government on Wednesday approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin.
-
Corbevax Cleared As Covid Booster Shot For Those 18 And Above
Biological E's COVID-19 vaccine Corbevax has been cleared for booster shot for those 18 and above.
-
Vaccine For 12-14 Age Group: Delhi Parents Feel Relieved, Say Apt Move Ahead Of School Reopening
The COVID-19 vaccine to be administered to the 12-14 years age group would be Corbevax manufactured by Biological E. Limited, Hyderabad.
-
Centre Releases Guidelines For Covid Vaccination Of 12-14 Age Group
The Centre today released guidelines for COVID-19 vaccination of children between 12-14 years that will begin from March 16 and said only Corbevax vaccine would be used for the beneficiaries of this age group.
-
Influential US Congress Members Urge Vaccine Collaboration With India
Members of America's influential Congressional Hispanic Caucus have urged US President Joe Biden to champion vaccine collaboration with India to bring an end to the COVID-19 pandemic.
-
Biological E's Corbevax Is Second Covid Vaccine For Children In India
A second COVID-19 vaccine for children has received emergency use authorisation in India. Biological E Ltd's Corbevax has got EUA for children and teens between 12 and 18 years, the vaccine-maker said in a statement today.
-
Pharma Stocks Gain After Centre Approves Use Of COVID Pill Molnupiravir
Pharma Stocks Today: Pharmaceutical shares such as Cipla, Dr Reddy's Laboratories, Torrent Pharma, Sun Pharma Industries gained around two per cent each on Wednesday
-
Biological E Aims To Produce 100 Million Doses Of Corbevax Every Month From Feb 2022
Biological E. Limited plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating over 100 million doses per month from February 2022.
-
Will 2 New Vaccines Be Used As Boosters? Decision "Within Days"
The government will soon take a call whether the two new Covid vaccines approved today -- Corbevax and Covovax -- may be used for booster doses. Sources told NDTV that a decision is expected "within days".
-
India's 2 New Covid Vaccines: What You Need To Know
The two latest vaccines cleared by India are Corbevax and Covovax. The anti-viral drug Molnupiravir can be used during emergency.
-
India Clears 2 New Vaccines And Merck's Covid Pill: 10 Points
The centre cleared two more vaccines today and one anti-viral drug to boost the fight against the COVID-19 pandemic. The two latest vaccines cleared by India are Corbevax and Covovax. The anti-viral drug Molnupiravir can be used during emergency.
-
Hyderabad's Biological E Expects To Rollout Corbevax Covid Vaccine By November-End
Biological E. Limited (BE) is expecting its COVID-19 vaccine Corbevax to be rolled out by the end of November even as the city-based firm is getting ready with 100 million doses for the launch, Mahima Datla, Managing Director, BE said on Monday.
-
Biological E Seeks Regulator's Nod For Phase-3 Trial Of Booster Dose
Biological E has sought permission from India's drug regulator to conduct the phase-3 clinical trial for its COVID-19 vaccine Corbevax as a single booster dose for those who have been fully vaccinated with Covishield or Covaxin.
